The ROE as of November 2025 (TTM) for PHAXIAM Therapeutics S.A. (PHXM) is -95.68%

According to PHAXIAM Therapeutics S.A.’s latest financial reports and current stock price. The company's current ROE is -95.68%. This represents a change of 313.45% compared to the average of -23.14% of the last 4 quarters.

PHAXIAM Therapeutics S.A. (PHXM) Historical ROE (quarterly & annually)

How has PHXM ROE performed in the past?

The mean historical ROE of PHAXIAM Therapeutics S.A. over the last ten years is -98.01%. The current -95.68% ROE has changed -2.38% with respect to the historical average. Over the past ten years (40 quarters), PHXM's ROE was at its highest in in the December 2022 quarter at 3.39%. The ROE was at its lowest in in the December 2020 quarter at -144.46%.

PHAXIAM Therapeutics S.A. (PHXM) ROE by Quarter and Year

Discovering the peaks and valleys of PHAXIAM Therapeutics S.A. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

PHAXIAM Therapeutics S.A. (PHXM) Average ROE

How has PHXM ROE performed in the past?

The current ROE of PHAXIAM Therapeutics S.A. (PHXM) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

PHAXIAM Therapeutics S.A. (PHXM) ROE vs. Peers

How is PHXM’s ROE compared to its peers?

PHAXIAM Therapeutics S.A.’s ROE is greater than MEI Pharma, Inc. (-27.11%), less than Nymox Pharmaceutical Corporation (24.07%), greater than MetaVia Inc. (-212.00%), greater than Traws Pharma, Inc. (-142.11%), greater than COSCIENS Biopharma Inc. (-149.40%), greater than Pieris Pharmaceuticals, Inc. (-58.40%), less than Dominari Holdings Inc. (116.21%), greater than Elevation Oncology, Inc. (-74.68%), greater than AlphaTON Capital Corp. (-738.96%), less than Kineta, Inc. (71.50%),

Build a custom stock screener for PHAXIAM Therapeutics S.A. (PHXM) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like PHAXIAM Therapeutics S.A. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

PHAXIAM Therapeutics S.A. (PHXM) and other stocks custom spreadsheet templates

The easiest way to analyze a company like PHAXIAM Therapeutics S.A. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.